The purpose of this study is to compare treatment with both teriparatide and raloxifene with
teriparatide alone. The study will evaluate any side effects that may be associated with
the two drugs and may help to determine whether teriparatide and raloxifene together can
help patients with osteoporosis more than teriparatide alone.
Inclusion Criteria
- Must be diagnosed with osteoporosis.
- Must be female, age 45 through 85.
- Must be at least 5 years postmenopausal.
- Must be free of other severe or chronically disabling conditions.
- Must be able to properly use injection device.
Exclusion Criteria
- Must not have bone diseases other than osteoporosis.
- Must not have history of certain cancers.
- Must not have certain medical diseases (inflammatory bowel disease, malabsorption
syndrome, kidney or bladder stones, venous thrombi or emboli, recent vaginal bleeding
due to unknown causes).
- Must not have taken or are currently taking certain types of medicines.
- Must not have known allergy to the study agent or SERM.
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Anaheim, California 92801, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Oakland, California 94612, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Altamonte Springs, Florida 32714, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Chicago, Illinois 60622, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Cedar Rapids, Iowa 52401, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Baltimore, Maryland 21204, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Hagerstown, Maryland 21740, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Voorhees, New Jersey 08043, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Cleveland, Ohio 44195, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Oklahoma City, Oklahoma 73109, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Portland, Oregon 97213, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Duncansville, Pennsylvania 16635, United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Dallas, Texas 75231, United States
